Inclusion criteria | |
Population | Adults or children with chronic hepatitis B or C in whom assessment of liver fibrosis is indicated |
Intervention | The Virtual Touch™ Quantification (VTq) software application used with the Siemens Virtual Touch™ Tissue Imaging systems (the Acuson S2000™ or S3000™ ultrasound platforms) |
Outcomes | Correlation in assessment of stage of liver disease Sensitivity and specificity (using AUROC) in assessment of liver fibrosis Correlation in assessment of stage of fibrosis using Metavir score Use of antiviral drugs Quality-of-life measures Hospital bed usage and length of stay Requirement for liver biopsy Device-related adverse events |
Study design | Diagnostic accuracy studies |
Language restrictions | English language only Foreign language papers with English abstracts could be included |
Search dates | 2009–current |
Exclusion criteria | |
Population | Mixed patient cohort, use of a fibrosis score other than Metavir, overlapping cohorts with other identified populations |
Study design | Case studies, editorials, letters, reviews |
Interventions | No restriction |
AUROC area under receiver operating characteristic